Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.

By Chrystal U. Louis, B. Savoldo, G. Dotti, M. Pule, E. Yvon, G. D. Myers, C. Rossig, H. Russell, O. Diouf, E. Liu and 7 more. Blood, 2011

1,128 citations recorded by the source corpus.

Subfields: Immunology, Neurology, Oncology

View Paper: https://www.semanticscholar.org/paper/113fec801736a932fc1cbb009b57a50755620b56

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. S. Rosenberg
2. N. Restifo
3. M. Dudley
4. M. Smyth
5. N. Haynes
6. Guido Kroemer
7. L. Zitvogel
8. T. Gajewski

In Oncology

1. S. Rosenberg
2. N. Restifo
3. M. Dudley
4. M. Smyth
5. C. June
6. T. Gajewski
7. Guido Kroemer
8. L. Zitvogel

Citations in the corpus

• Adoptive immunotherapy for cancer: harnessing the T cell response (2012, positive): “Şimdilerde, doğal olarak oluşup tümörlere infiltre olan T hücre populasyonu sadece melanomlardan izole edilip geliştirilmesine rağmen, hemen hemen tüm tümör hücre türleri tümör hücre yüzeyini tanımak üzere geliştirilmiş T hücreleri (5, 6, 16, 72, 73) tarafından lizise uğratılabilir ve bu T hücreleri”
• Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells (2013, background): “reports of long-term remission in some cases (5, 7).”